Technology
Meta rolls out web version of Threads
Meta Platforms said on Tuesday it was launching the web version of its new text-first social media platform Threads, in a bid to retain professional users and gain an edge over rival X, formerly Twitter.
Threads' users will be able to access the microblogging platform by logging-in to its website from their computers, the Facebook and Instagram owner said.
Meta CEO Mark Zuckerberg said in a Threads post that the web version would reach users "over the next few days."
The widely anticipated roll out could help Threads gain broader acceptance among power users like brands, company accounts, advertisers and journalists, who can now take advantage of the platform by using it on a bigger screen.
Threads, which crossed 100 million sign-ups for the app within five days of its launch on July 5, saw a decline in its popularity as users returned to the more familiar platform X after the initial rush.
In just over a month, daily active users on Android version of Threads app dropped to 10.3 million from the peak of 49.3 million, according to a report, dated August 10, by analytics platform Similarweb.
The company will be adding more functionality to the web experience in the coming weeks, Meta said.
-
Technology14h ago
Animal behavior research is getting better at keeping observer bias from sneaking in – but there’s still room to improve
-
Technology14h ago
A look inside the cyberwar between Israel and Hamas reveals the civilian toll
-
Technology1d ago
US judge questions Google, DOJ in market power trial closing
-
Technology1d ago
Qualcomm jumps as AI sparks rebound in Chinese smartphone market
-
Technology1d ago
Boeing’s Starliner is about to launch − if successful, the test represents an important milestone for commercial spaceflight
-
Technology1d ago
Breakthrough 6G antenna could lead to high-speed communications and holograms
-
Technology2d ago
What You Need to Know About the New WhatsApp Features
-
Technology2d ago
Brain cancer in children is notoriously hard to treat – a new mRNA cancer vaccine triggers an attack from within